• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review - Product Image

Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review

  • Published: April 2013
  • Region: Global
  • 49 pages
  • GlobalData

FEATURED COMPANIES

  • Alpex Pharma SA
  • Cytos Biotechnology AG
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • Mymetics Corporation
  • Novartis AG
  • MORE

Summary

Actelion Ltd. (Actelion) is a biopharmaceutical company. It discovers, develops and commercializes innovative treatments, which serve considerable unmet medical needs. Actelion pioneered the development of endothelin receptor antagonists (ERA). The company’s major products include Tracleer (bosentan) for the treatment of pulmonary arterial hypertension; Ventavis (iloprost), an inhaled synthetic analog of prostacyclin; Veletri (epoprostenol for injection, an intravenous prostacyclin; and Zavesca (miglustat), low-molecular-weight inhibitor. The company operates across Switzerland, United States, Europe and Other. Actelion is headquartered in Allschwil, Switzerland.

Actelion Ltd Key Recent Developments

Feb 14, 2013: Actelion Reports Revenue Of CHF1.7 Billion In 2012
Oct 18, 2012: Actelion Reports Revenue Of CHF1.3 Billion For Nine Months Ended September 30, 2012
Sep 11, 2012: Actelion Implements Cost Saving Initiative, Eliminates Maximum Of 40 Jobs In Switzerland
Jul 19, 2012: Actelion Reports Revenue Of CHF861.8m In H1 2012
Jul 12, 2012: Actelion Announces Cost Saving Initiative To Be Implemented By 2012

This comprehensive SWOT profile READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
Actelion Ltd - Key Facts
Actelion Ltd - Key Employees
Actelion Ltd - Key Employee Biographies
Actelion Ltd - Major Products and Services
Actelion Ltd - Pharmaceutical Pipeline Products Data
Actelion Ltd, Pipeline Products by Therapy Area
Actelion Ltd, Pipeline Products by Development Phase
Actelion Ltd - History
Actelion Ltd - Company Statement
Actelion Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Actelion Ltd - Business Description
Actelion Ltd - SWOT Analysis
SWOT Analysis - Overview
Actelion Ltd - Strengths
Strength - Marketed Products
Strength - Widespread Geographic Reach
Strength - Focused R&D Activities
Strength - Increase in Profitability
Actelion Ltd - Weaknesses
Weakness - Legal Proceedings
Actelion Ltd - Opportunities
Opportunity - Market Potential: PAH
Opportunity - Changing Demographics
Opportunity - New Developments
Opportunity - Products Pipeline
Actelion Ltd - Threats
Threat - Growing Parallel Trade
Threat - Uncertain R&D Outcomes
Threat - Cost Containment Pressures
Actelion Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Actelion Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Actelion Ltd, Recent Developments
Feb 14, 2013: Actelion Reports Revenue Of CHF1.7 Billion In 2012
Oct 18, 2012: Actelion Reports Revenue Of CHF1.3 Billion For Nine Months Ended September 30, 2012
Sep 11, 2012: Actelion Implements Cost Saving Initiative, Eliminates Maximum Of 40 Jobs In Switzerland
Jul 19, 2012: Actelion Reports Revenue Of CHF861.8m In H1 2012
Jul 12, 2012: Actelion Announces Cost Saving Initiative To Be Implemented By 2012
May 08, 2012: Actelion Presents Strategy For Value Creation
Apr 19, 2012: Actelion Reports Revenue Of CHF417.5m In Q1 2012
Feb 14, 2012: Actelion Reports Revenue Of CHF424.4m In Q4 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Actelion Ltd, Key Facts
Actelion Ltd, Key Employees
Actelion Ltd, Key Employee Biographies
Actelion Ltd, Major Products and Services
Actelion Ltd, Number of Pipeline Products by Therapy Area
Actelion Ltd, Number of Pipeline Products by Development Stage
Actelion Ltd, Pipeline Products By Therapy Area and Development Phase
Actelion Ltd, History
Actelion Ltd, Subsidiaries
Actelion Ltd, Key Competitors
Actelion Ltd, Ratios based on current share price
Actelion Ltd, Annual Ratios
Actelion Ltd, Interim Ratios
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Actelion Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Actelion Ltd, Pipeline Products by Therapy Area
Actelion Ltd, Pipeline Products by Development Phase
Actelion Ltd, Performance Chart (2008 - 2012)
Actelion Ltd, Ratio Charts
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Actelion Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Santhera Pharmaceuticals Holding AG
Novartis AG
Mymetics Corporation
Merck Serono S.A.
F. Hoffmann-La Roche Ltd.
Alpex Pharma SA
Cytos Biotechnology AG
Anavex Life Sciences Corp.

Note: Product cover images may vary from those shown

RELATED PRODUCTS